MICROPORT NEURO (02172) spent approximately HKD 1.9513 million to repurchase 250,000 shares on September 19th.
Minimally Invasive Neurosciences (02172) announced on September 19, 2024, to repurchase approximately 1.9513 million Hong Kong dollars...
MICROPORT NEURO (02172) has announced on September 19, 2024, that they will repurchase 250,000 shares at a cost of approximately 1.9513 million Hong Kong dollars. The repurchase price per share is between 7.77 and 7.86 Hong Kong dollars.
Related Articles
Xiamen Amoytop Biotech (688278.SH) plans to issue convertible bonds to raise no more than 1.533 billion yuan.
CHINARES PHARMA (03320) subsidiary China Resources Double-Crane Pharmaceutical has been approved to issue corporate bonds totaling 3 billion yuan.
Shanghai Anlogic Infotech (688107.SH) plans to raise up to 1.262 billion yuan through a private placement.
Xiamen Amoytop Biotech (688278.SH) plans to issue convertible bonds to raise no more than 1.533 billion yuan.
CHINARES PHARMA (03320) subsidiary China Resources Double-Crane Pharmaceutical has been approved to issue corporate bonds totaling 3 billion yuan.
Shanghai Anlogic Infotech (688107.SH) plans to raise up to 1.262 billion yuan through a private placement.
RECOMMEND
Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026
Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026
Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026
